Covered recipient · General Payments record
KAITLYN WYATT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2025
$2,909.99
- Reported across 177 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.82 | 35 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $178.07 | 22 |
| Novo Nordisk AS | $71.88 | 3 |
| Amgen Inc. | $50.06 | 3 |
| ITI, Inc. | $40.05 | 2 |
| Acerta Pharma LLC | $34.96 | 2 |
| GlaxoSmithKline, LLC. | $21.17 | 1 |
| Astellas Pharma US Inc | $19.34 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.50 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218542 | CMS |
| ABBVIE INC. | $19.26 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218548 | CMS |
| ABBVIE INC. | $12.78 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218552 | CMS |
| ABBVIE INC. | $10.43 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218560 | CMS |
| ABBVIE INC. | $13.32 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218566 | CMS |
| ABBVIE INC. | $6.67 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218571 | CMS |
| ABBVIE INC. | $6.05 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218577 | CMS |
| ABBVIE INC. | $6.29 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218584 | CMS |
| ABBVIE INC. | $6.52 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218590 | CMS |
| ABBVIE INC. | $5.14 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218595 | CMS |
| ABBVIE INC. | $6.26 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218602 | CMS |
| ABBVIE INC. | $10.52 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218609 | CMS |
| ABBVIE INC. | $5.10 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218616 | CMS |
| ABBVIE INC. | $5.59 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218620 | CMS |
| ABBVIE INC. | $6.78 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218626 | CMS |
| ABBVIE INC. | $9.56 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218630 | CMS |
| ABBVIE INC. | $5.88 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218636 | CMS |
| ABBVIE INC. | $6.67 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218640 | CMS |
| ABBVIE INC. | $7.73 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218648 | CMS |
| ABBVIE INC. | $7.94 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218654 | CMS |
| ABBVIE INC. | $10.29 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218662 | CMS |
| ABBVIE INC. | $3.79 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204218669 | CMS |
| Amgen Inc. | $18.45 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228871713 | CMS |
| Amgen Inc. | $15.39 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228871701 | CMS |
| Amgen Inc. | $16.22 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228871706 | CMS |
| Astellas Pharma US Inc | $19.34 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238730858 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.53 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206412716 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.43 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206545887 | CMS |
| GlaxoSmithKline, LLC. | $21.17 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191687503 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.29 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241726997 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.76 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241726999 | CMS |
| Novo Nordisk Inc | $24.38 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188241353 | CMS |
| Novo Nordisk Inc | $19.86 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188315491 | CMS |
| Novo Nordisk Inc | $27.64 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188466928 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.29 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219310593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.